ArabFinance: Ibnsina Pharmas (ISPH) consolidated net profit reached EGP 224.66 million in 2020, down 31.6% when compared to EGP 328.77 million in 2019, excluding minority shareholders rights, the company reported to the Egyptian Exchange on March 1st.

The companys standalone net profit stood at EGP 224.78 million last year, compared to EGP 328.77 million in 2019.

Ibnsina reported an 18% Year on Year decline in its net profit in the first nine months of 2020, registering EGP 200.61 million, compared to EGP 245.62 million in the same period of 2019.

Ibnsina is an Egypt-based pharmaceutical distribution company. The company distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.

Copyright 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.